Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beverly Z Packard

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Molecular Therapy. Methods & Clinical Development|January 19, 2026
<i>In vivo</i> delivery of a fluorogenic antisense oligonucleotide into human leukocytes in a humanized mouse model systemNathan B Seidel, Saurav S Rout, Beverly Z Packard, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 21, 2004
Assessment of lymphocyte-mediated cytotoxicity using flow cytometryLuzheng Liu, Beverly Z Packard, Martin J Brown, et al.
Experimental Cell Research|June 14, 2002
The effector phase of physiological cell death relies exclusively on the posttranslational activation of resident componentsSandra H Chang, Marija Cvetanovic, Kevin J Harvey, et al.
Nature Medicine|February 1, 2002
Visualization and quantification of T cell-mediated cytotoxicity using cell-permeable fluorogenic caspase substratesLuzheng Liu, Ann Chahroudi, Guido Silvestri, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|July 8, 2011
High-throughput quantitative analysis of HIV-1 and SIV-specific ADCC-mediating antibody responsesJustin Pollara, Lydia Hart, Faraha Brewer, et al.
Journal of Virology|May 31, 2013
IFITM-2 and IFITM-3 but not IFITM-1 restrict Rift Valley fever virusRajini Mudhasani, Julie P Tran, Cary Retterer, et al.
Immunity|December 9, 2008
Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune controlStephen A Migueles, Christine M Osborne, Cassandra Royce, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Molecular Therapy. Methods & Clinical Development|January 19, 2026
<i>In vivo</i> delivery of a fluorogenic antisense oligonucleotide into human leukocytes in a humanized mouse model systemNathan B Seidel, Saurav S Rout, Beverly Z Packard, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 21, 2004
Assessment of lymphocyte-mediated cytotoxicity using flow cytometryLuzheng Liu, Beverly Z Packard, Martin J Brown, et al.
Experimental Cell Research|June 14, 2002
The effector phase of physiological cell death relies exclusively on the posttranslational activation of resident componentsSandra H Chang, Marija Cvetanovic, Kevin J Harvey, et al.
Nature Medicine|February 1, 2002
Visualization and quantification of T cell-mediated cytotoxicity using cell-permeable fluorogenic caspase substratesLuzheng Liu, Ann Chahroudi, Guido Silvestri, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|July 8, 2011
High-throughput quantitative analysis of HIV-1 and SIV-specific ADCC-mediating antibody responsesJustin Pollara, Lydia Hart, Faraha Brewer, et al.
Journal of Virology|May 31, 2013
IFITM-2 and IFITM-3 but not IFITM-1 restrict Rift Valley fever virusRajini Mudhasani, Julie P Tran, Cary Retterer, et al.
Immunity|December 9, 2008
Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune controlStephen A Migueles, Christine M Osborne, Cassandra Royce, et al.
Pageof 2